Combination of all-trans retinoic acid and lithium chloride surmounts a retinoid differentiation block induced by expression of Scl and Rbtn2 transcription factors in myeloid leukemia cells

Leukemia Research

Volumn 28, Issue 4, 2004, Pages 399-403

  Rice, Anna M ^a   Li, Jianming ^a,b   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

All trans retinoic acid; HL60; Leukemia cells; LiCl; Rbtn2; Scl; WEHI D+

Indexed keywords

LITHIUM CHLORIDE; RETINOIC ACID; TRANSCRIPTION FACTOR RBTN2; TRANSCRIPTION FACTOR SCL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 1042300992     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.08.011     Document Type: Article

References (23)

1. Chen Z.X., Xue Y.Q., Zhang R., Tao R.F., Xia X.M., Li C.et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood. 78:1991;1413-1419.
2. Warrell R.P. Jr., Frankel S.R., Miller W.H. Jr., Scheinberg D.A., Itri L.M., Hittelman W.N.et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324:1991;1385-1393.
3. Maslak P., Scheinberg D. Targeted therapies for the myeloid leukemias. Exp. Opin. Invest. Drugs. 9:2000;1197-1205.
4. Miller W.H.J., Kakizuka A., Frankel S.R. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2694-2698.
5. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77:1990;2936-2940.
6. Atsumi Y., Dodd R.C., Maddux F.W., Citron S.J., Gray T.K. Retinoids induce U937 cells to express macrophage phenotype. Am. J. Med. Sci. 292:1986;152-156.
7. Yang T., Buchan H.C., Townsend K.J., Craig R.W. Mcl-1, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J. Cell. Physiol. 166:1996;523-536.
8. + monomyelocytic leukemia cells by retinoic acid and aclacinomycin A. Cancer Res. 46:1986;1189-1194.
9. Warner N.L., Moore M.A.S., Metcalf D. A transplantable myelomonocytic leukemia in BALB/c mice: cytology, karyotype and muramidase content. J. Int. Cancer Inst. 43:1969;963-982.
10. Metcalf D., Nicola N.A. Autoinduction of differentiation in WEHI-3B leukemia cells. Int. J. Cancer. 30:1982;773-780.
11. -. Cell Growth Differ. 5:1994;557-561.
12. Visvader J., Begley C.G., Adams J.M. Differential expression of the Lyl, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 6:1991;187-194.
13. Mouthon M.A., Bernare O., Mitjavila M.T., Romeo P.H., Vainchenker W., Mathieu-Mahul D. Expression of Tal-1 and GATA-binding proteins during hematopoiesis. Blood. 81:1993;647-655.
14. Voronova A.F., Lee F. The E2A and Tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5952-5956.
15. Wadman I.A., Osada H., Grutz G.G., Agulnick A.D., Westphal H., Forster A.et al. The Lim-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/ NL1 proteins. EMBO J. 16:1997;3145-3157.
16. Hsu H.-L., Huan L., Tsan J.T., Funck W., Wright W.E., Hu J.-S.et al. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol. 14:1994;1256-1265.
17. Lécuger E., Herblot S., Saint-Denis M., Martin R., Begley C.G., Porcher C.et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood. 100:2002;2430-2440.
18. - leukemia cells. Exp. Cell. Res. 242:1998;274-284.
19. Chen Q., Cheng J.-T., Tsai L.-H., Schneider N., Buchanan G., Carroll A. et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:1990;415-424.
20. Brown L., Cheng J.-T., Chen Q., Siciliano M.J., Crist W., Buchanan G.et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 9:1990;3343-3351.
21. Finch R.A., Li J., Chou T.C., Sartorelli A.C. Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid-treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiation. Blood. 96:2000;2262-2268.
22. + leukemia cells by lithium chloride. Leukemia Res. 17:1993;403-410.
23. Chou T-C. The median-effect principle and the combination index for quantitation of synergism and antagonism. In: Chou T-C, Rideout DC, editors. Synergism and antagonism in chemotherapy. New York: Academic Press; 1991. p. 61-102.